Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
OTC Drugs

No Disguising Need For Enforcement, Education To Curb Counterfeiting

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

Consumer education programs and increased law enforcement efforts are needed to curtail the counterfeiting of drugs and personal care products, according to a lawyer with a prominent intellectual property law firm

You may also be interested in...



Formulating With TruTag Could Help Protect Drugs Against Counterfeiting

Cellular Bioengineering Inc. is touting its biologically inert TruTag technology as an advanced layer of anti-counterfeiting protection for goods ranging from pharmaceuticals and cosmetics to airplane parts and works of art

Formulating With TruTag Could Help Protect Drugs Against Counterfeiting

Cellular Bioengineering Inc. is touting its biologically inert TruTag technology as an advanced layer of anti-counterfeiting protection for goods ranging from pharmaceuticals and cosmetics to airplane parts and works of art

Formulating With TruTag Could Help Protect Drugs Against Counterfeiting

Cellular Bioengineering Inc. is touting its biologically inert TruTag technology as an advanced layer of anti-counterfeiting protection for goods ranging from pharmaceuticals and cosmetics to airplane parts and works of art

Table

View full table

Related Content

Pink Sheet

Topics

Tags:
OTC Drugs
Latest Headlines

Patent Office Issues Proposed Rule For Rarely Successful Director Review Requests

Medicare Spending Forecast For Leqembi Reflects CMS Angst About Alzheimer’s Drug Costs

US FDA Drugs Center Launches Clinical Trial Innovation Hub With Demonstration Projects

EMA Releases Guidance On How & When Its RWE Generation Service Can Be Used

See All
UsernamePublicRestriction

Register

PS101280

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By